<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) comprise a group of <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> clonal hematopoietic cell disorders characterized by cytopenias, bone marrow hypercellularity, and increased risk of transformation to <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> usually transformed to <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>, and transformation to <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) is rare </plain></SENT>
<SENT sid="2" pm="."><plain>Herein, we report a unique patient who presented with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Two months after the initial diagnosis, she progressed to a precursor B-cell <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>She was treated with induction therapy followed by allogenic stem cell transplantation </plain></SENT>
<SENT sid="5" pm="."><plain>She was alive and doing well upon last followup </plain></SENT>
<SENT sid="6" pm="."><plain>We have also reviewed the literature and discussed the clinicopathologic features of 36 MDS patients who progressed to ALL reported in the literature </plain></SENT>
</text></document>